Supplemental material
Bioengineered
Volume 13, 2022 - Issue 5
Open access
1,052
Views
1
CrossRef citations to date
0
Altmetric
Research Paper
Sufentanil alleviates pre-eclampsia via silencing microRNA-24-3p to target 11β-Hydroxysteroid dehydrogenase type 2
Yang Yuea Department of Obstetrics, Longhua District Maternity and Child Health Hospital, Shenzhen, Guangdong, ChinaView further author information
, Fu Xub Department of Anesthesiology, Longhua District People’s Hospital, Shenzhen, Guangdong, ChinaCorrespondence[email protected]
View further author information
, View further author information
JiaRong Zhanga Department of Obstetrics, Longhua District Maternity and Child Health Hospital, Shenzhen, Guangdong, ChinaView further author information
, Miao Zhaoa Department of Obstetrics, Longhua District Maternity and Child Health Hospital, Shenzhen, Guangdong, ChinaView further author information
& FangFang Zhoua Department of Obstetrics, Longhua District Maternity and Child Health Hospital, Shenzhen, Guangdong, ChinaView further author information
Pages 11456-11470
|
Received 06 Jan 2022, Accepted 10 Apr 2022, Published online: 04 May 2022
Related Research Data
Sufentanil alleviates pre-eclampsia via silencing microRNA-24-3p to target 11β-Hydroxysteroid dehydrogenase type 2
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.